Systematic review on socioeconomic deprivation and survival in endometrial cancer by Donkers, H. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/208574
 
 
 
Please be advised that this information was generated on 2020-09-09 and may be subject to
change.
Vol.:(0123456789) 
Cancer Causes & Control (2019) 30:1013–1022 
https://doi.org/10.1007/s10552-019-01202-1
REVIEW ARTICLE
Systematic review on socioeconomic deprivation and survival 
in endometrial cancer
H. Donkers1 · R. Bekkers2,3 · L. Massuger2 · K. Galaal1,4 
Received: 16 January 2019 / Accepted: 25 June 2019 / Published online: 8 July 2019 
© The Author(s) 2019
Abstract
Purpose The primary objectives in this review were to (1) assess the association between socioeconomic deprivation and 
survival in endometrial cancer patients (2) investigate if there is an association between socioeconomic deprivation and 
peri-operative morbidity in endometrial cancer patients.
Methods We performed a systematic review using Medline (1946–2018), Embase (1980–2018), Cinahl (1981–2018) and 
the Cochrane Controlled Register of Trials to identify studies that reported on the association between socioeconomic dep-
rivation and survival or peri-operative outcomes in endometrial cancer patients. Included were adult women (age ≥ 18 years) 
diagnosed with primary endometrial cancer. Two reviewers independently selected studies and assessed bias using the 
Newcastle–Ottawa assessment scale. Data extraction was completed using pre-determined forms, and summary tables of 
evidences from the included studies were created.
Results Nine studies were included in this review with a total number of 369,900 patients. Eight studies investigated survival 
and socioeconomic deprivation, and the majority showed that socioeconomic deprivation is associated with poorer survival 
in endometrial cancer patients. One study assessed the association between deprivation and peri-operative morbidity and 
found no difference in 30-day postoperative mortality.
Conclusions Socioeconomic deprivation seems to be associated with worse survival in endometrial cancer patients, even 
after adjusting for stage at diagnosis. However, the impacts of important confounders such as BMI, smoking and comorbidi-
ties are unclear and should be assessed. The relationship between socioeconomic deprivation and peri-operative morbidity 
is unclear, and further research is needed to evaluate this aspect. A standardised measure for socioeconomic deprivation is 
needed in order to establish adequate comparison between studies.
Keywords Endometrial cancer · Socioeconomic status · Survival · Morbidity
Introduction
Endometrial cancer is the sixth most commonly occurring 
cancer in women, with over 380,000 estimated new cases 
worldwide and nearly 90,000 estimated deaths in 2018 [1]. 
Both incidence and mortality rates have increased over the 
last decades, with obesity being one of the main risk factors 
[2]. The increase in obesity has multiple underlying factors 
including socioeconomical factors, with a strong association 
between obesity and lower socioeconomic status (SES) in 
endometrial cancer patients and in the general population 
[3, 4].
Socioeconomic status (SES) is a measure of an individ-
ual’s economic and sociological standing and is based on 
income, education and occupation [5]. SES is considered to 
be an important predictor of health due to health inequali-
ties [6]; however, the relationship between socioeconomic 
deprivation and cancer is complex and multifaceted. The 
incidence of various cancers including endometrial cancer 
is higher in deprived groups [7]. Furthermore, death rates 
are examined extensively and are shown to be higher among 
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the most deprived for most types of cancer [8]. However, the 
relationship between socioeconomic deprivation and sur-
vival in endometrial cancer patients is not fully established.
Whilst Body Mass Index (BMI) is related to SES and 
obesity is associated with an increased risk of surgical mor-
bidity in endometrial cancer patients [9], the relationship 
between socioeconomic deprivation and peri-operative mor-
bidity is unclear.
In this systematic review, our aim is to establish the rela-
tionship between socioeconomic deprivation and survival in 
endometrial cancer patients. In addition, we aim to investi-
gate the correlation between socioeconomic deprivation and 
peri-operative morbidity.
Objectives
• To evaluate the association between socioeconomic dep-
rivation and survival in endometrial cancer patients.
• To assess the correlation between socioeconomic depri-
vation and peri-operative morbidity in endometrial can-
cer patients.
Methods
Study design
We conducted a systematic review of the literature to address 
the subject of socioeconomic deprivation and survival in 
endometrial cancer patients.
Eligibility criteria
We have used the following definition by Peter Townsend, 
sociologist, of socioeconomic deprivation: a lack of social 
and economic benefits which are considered to be basic 
necessities in a society [10]. We have included studies with 
individual, area-based or both types of measures of socio-
economic deprivation in this review.
The following criteria were used to exclude articles from 
further consideration: not in English, contained no origi-
nal data, meeting abstract only (no full article for review) 
or article did not apply to any of the review questions. We 
furthermore excluded articles that used indirect measures of 
socioeconomic deprivation such as marriage or insurance 
status only.
Types of studies
We included all study designs evaluating the association 
between socioeconomic status and survival or peri-opera-
tive outcomes in endometrial cancer patients as a primary 
outcome.
Types of participants
• Adult women (age ≥ 18 years) diagnosed with primary 
endometrial cancer.
Search strategy and selection criteria
This review was performed according to Preferred Reporting 
Items for Systematic reviews and Meta-Analyses (PRISMA) 
guidelines, and in accordance with the principles outlined 
in the Cochrane Handbook [11]. We performed systematic 
searches in Medline (1946 until May 2018), Embase (1980 
until May 2018) and Cinahl (1981 until May 2018) and 
the Cochrane Controlled Register of Trials. Search strate-
gies were adapted accordingly to each database. The used 
search strategies are presented in Appendix 1. In addition, 
we searched grey literature including abstracts of scientific 
meetings as well as manually checking the reference lists of 
eligible studies to identify any additional studies to include 
in this review.
Types of outcome measures
• Primary outcomes Survival including overall survival 
(OS), cause-specific survival (CSS) and recurrence-free 
survival (RFS).
• Secondary outcomes Peri-operative morbidity in terms of 
peri-operative complications (intra-operative complica-
tions including nerve injury, bowel injury, bladder injury, 
ureter injury and vascular injury and postoperative com-
plications including wound problems, fascia dehiscence, 
ileus, urinary tract infection, haemorrhage, pneumonia, 
pelvic abscess, haematoma, venous thromboembolism, 
sepsis, renal complications, cardiac complication and 
organ failure) and 30-day mortality.
Study selection
Two reviewers (HD and KG) independently assessed titles 
and abstracts of all identified studies. Those studies that 
clearly did not meet the inclusion criteria were excluded. 
Potentially relevant studies were retrieved in full text and 
were further reviewed for eligibility by both reviewers.
Data extraction
Data extraction was completed by two of the authors (HD 
and KG) using pre-determined forms which included study 
author names, publication dates, study designs, sample sizes, 
measures of socioeconomic deprivation, results of uni-
variate analyses testing for zero-order association between 
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socioeconomic deprivation and survival or peri-operative 
outcomes and the results of the multivariate analyses test-
ing for association between socioeconomic deprivation and 
survival or peri-operative outcomes adjusting for control 
variables. Differences were resolved by consensus.
Assessment of risk bias
The risk of bias included in studies was assessed by two 
authors (HD and KG) independently using the Newcas-
tle–Ottawa Quality Assessment Form for Cohort Studies 
which includes selection, comparability and outcome [12]. 
Differences were resolved by consensus.
Data synthesis
We were unable to conduct a meta-analysis because of the 
heterogeneity in the included studies. However, we created 
summary tables of evidence from the included studies and 
then examined the relationship between various measures 
of socioeconomic deprivation and outcomes across studies.
Results
Study selection
The search strategy identified 127 references in Medline, 183 
in Embase and 35 in Cinahl. Search results were merged, and 
duplicates were removed, resulting in 247 unique studies. 
After screening title and abstract, 16 articles were retrieved 
in full text and were further assessed for eligibility. Sub-
sequently seven studies were considered eligible for this 
review, and a further search of the grey literature identified 
two articles, resulting in the inclusion of nine articles in this 
review (Fig. 1).
Study characteristics
The characteristics of the nine studies included in this review 
are illustrated in Table 1. All studies combined resulted in 
a total of 369,900 endometrial cancer patients, and all stud-
ies were of retrospective design. Eight studies included 
all stages of endometrial cancer, whereas one study only 
included stages I to II endometrioid adenocarcinoma.
Fig. 1  PRISMA flow diagram
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Different measures of socioeconomic deprivation were 
used: income, level of education, unemployment, social 
class, housing tenure and insurance status. Furthermore, 
two studies used the Income Domain of the English Indices 
of Multiple Deprivation (IMD), which are published by the 
UK Department for Communities and Local Government 
and measure a spectrum of deprivation [13].
Risk of bias of included studies
We have assessed the risk of bias with the Newcastle–Ottawa 
scale. Two studies were of poor quality, and seven studies 
were of good quality (see Fig. 2).
Synthesis of results
Socioeconomic deprivation and survival
Eight studies with 331,568 endometrial cancer patients 
assessed survival and socioeconomic deprivation, see 
Table 1. A study done by The National Cancer Intelligence 
Network (NCIN) used the income domain of IMD and 
showed a relationship between deprivation and mortality in 
England, with a higher mortality rate in the more income-
deprived groups [14]. However, they did not adjust for any 
confounders.
Furthermore, three studies [15–17] used the median 
household income as a measure of SES of which two stud-
ies (Madison et al. and Robbins et al.) found an association 
between mortality and deprivation, with a higher income 
being associated with a decreased risk of death [15, 16]. 
However, in a multivariate analysis, Robbins et al. did not 
identify SES as a significant predictor of patient outcome, 
while in the study done by Madison et al., the significance 
remains after adjusting for stage. The third study done by 
Fader et al. [17] found no difference either in overall sur-
vival or recurrence-free survival within the different income 
groups or educational levels, even after adjusting for stage.
The study done by Cheung et al. [18] looked at county-
level family income and found a decreased survival in 
patients living in low-income neighbourhood, which did not 
remain significant in multivariate analysis, while a study 
done by Ueda et al. [19] used municipality-based SES and 
found poorer 5-year survival in the low unemployment and 
education municipalities, even after adjusting for stage. The 
study done by Jensen et al. [20] used six different socioeco-
nomic indicators and found no strong association between 
socioeconomic variables and survival, but survival tended to 
be better for women with higher education and more dispos-
able income; however, they did not correct for confounders. 
Lastly, a study done by Seidelin et al. [21] showed education 
to be associated with higher hazard ratio (HR) for death, EC
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even after adjusting for confounders such as stage at diag-
nosis, BMI and comorbidities.
Socioeconomic deprivation and peri‑operative morbidity
A study done by Gildea et al. [22] used the income domain 
of the English IMD to assess the relationship between post-
operative mortality and deprivation, and found no associa-
tion between income deprivation and 30-day postoperative 
mortality. No other articles were found, which investigated 
the association between deprivation and peri-operative mor-
bidity in endometrial cancer patients.
Discussion
This review summarises the current literature about the asso-
ciation between socioeconomic deprivation and survival in 
endometrial cancer patients. The results of this systematic 
review suggest a worse survival for more socioeconomi-
cally deprived patients, with six studies showing low SES 
being associated with worse survival in univariate analysis, 
and three studies confirming poor outcome in multivariate 
analysis. However, two studies did not show an association.
Previous research has looked at possible explanations for 
the differences in cancer survival within different groups of 
deprivation, with stage at diagnosis being one of the most 
important factors [23]. In cervical, breast and colorectal can-
cer these survival differences are related to the differences in 
participation rate in cancer screening programmes, in which 
women with lower SES and women living in urban areas are 
less likely to participate [24]. For endometrial cancer, there 
is no routine screening; however, since patients present early 
with bleeding problems, it is usually diagnosed at an early 
stage, which leads to high survival rates [14]. This suggests 
that SES impacts survival in endometrial cancer through 
other factors which may include BMI, age, smoking and 
comorbidities.
For endometrial cancer, factors that are associated with 
advanced stage at diagnosis include high-grade lesions, 
serous histologic subtype, older age and low SES [21, 25, 
26]. Patients with higher socioeconomic position might be 
more aware of symptoms and present quicker to a general 
practitioner or medical specialist, while low-SES patients 
tend to ignore early symptoms of disease such as postmeno-
pausal bleeding [21]. This could partially explain the dif-
ferences in survival; however, most studies included in this 
review with the exception of two (Jensen et al. and NCIN) 
corrected for stage at diagnosis in their analyses. Therefore, 
it seems that regardless of stage at diagnosis, socioeconomic 
deprivation affects survival in endometrial cancer patients.
Other important factors in cancer survival in general and 
in endometrial cancer patients include BMI, with normal-
weight women having better survival than obese patients 
[23, 27]. One of the mechanisms that has been suggested to 
explain the differences in survival is the fact that obesity is 
associated with an increased risk of surgical morbidity [9]; 
however, some studies have shown that it is not an independ-
ent predictor but likely related to other comorbid conditions 
[28]. Since there is a strong relationship between obesity and 
socioeconomic deprivation in endometrial cancer patients 
[4], this could potentially be an important factor affecting 
survival in deprived patients; however, the articles included 
in this review, with the exception of Seidelin et al., did not 
include or correct for BMI.
A third factor in cancer survival is comorbidity, previ-
ous research has shown a decreased survival for endo-
metrial cancer patients with multiple comorbidities [29]. 
Different reasons are reported such as delayed diagnosis, 
higher rate of postoperative complications, a reduction of 
the possibility of surgery and a lower tolerance of oncolog-
ical treatment [30]. Since the prevalence of comorbidity 
tend to be higher among endometrial cancer patients with 
Fig. 2  Risk of bias (Newcastle–
Ottawa Scale)
Selection Comparability Outcome/exposure
NCIN, 2013 * * * - * * *
Madison, 2004 * * * * * * *
Robbins, 2013 * * * * * * *
Fader, 2016 * * * * * * *
Cheung, 2013 * * * - * * *
Udea, 2006 * * * * * * *
Jensen, 2008 * * * * * * *
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higher levels of deprivation [31], this could also affect sur-
vival. Of the articles included in this review, only Seidelin 
et al. corrected for comorbidity and found no difference in 
the odds ratio for death.
Furthermore age at diagnosis is an important factor in 
endometrial cancer survival [32]. Elderly patients often have 
more aggressive histology and are less likely to receive sur-
gical treatment or adjuvant therapy leading to under treat-
ment [33]. Furthermore an article by Poupon et al. [33] 
showed 3-year OS rates to be lower than cancer specific 
survival rate, indicating that death in elderly is often a com-
bination of death due to cancer as well as to causes other 
than cancer. All studies included in this review have adjusted 
for age at diagnosis with the exemption of Cheung et al. [18].
Another element in survival in endometrial cancer is 
treatment received by patients [34]. This is often influenced 
by patient characteristics such as age, comorbidities and 
patient preference. Furthermore, the type of treatment centre 
(cancer centre or smaller hospital) also influences the type 
of treatment offered to patients and influences survival in 
endometrial cancer patients [35, 36]. Patients with low SES 
are less likely to afford travel costs to cancer centres, espe-
cially if they reside in rural counties. Only half of the studies 
included in this review have taken treatment into account.
Lastly, smoking status is an important aspect in survival 
in endometrial cancer, in which smokers show worse sur-
vival compared to non-smokers [37], although some of 
the overall survival differences may be more attributable 
to associated comorbid conditions in smokers. None of the 
studies in this review have corrected for smoking status in 
their analysis.
BMI, comorbidities and smoking not only affect sur-
vival, but are also risk factors for peri-operative morbidity 
in endometrial cancer patients [9, 38, 39]. Because of the 
correlation of SES with BMI, comorbidities and smoking 
status, we have tried to investigate if there is a relationship 
between socioeconomic deprivation and peri-operative mor-
bidity; however, the current literature is scarce, and only 
one study was identified which did not show any associa-
tion between income deprivation and 30-day postoperative 
mortality [22]. Further research is needed to establish any 
relationship between socioeconomic deprivation and peri-
operative morbidity including 30-day mortality in endome-
trial cancer patients.
The studies in this review have used different measures 
of mortality (age-standardised mortality rate, survival time, 
disease-specific survival, overall survival, 1- and 5-year sur-
vival, etc.), which is an important issue when comparing 
results. Endometrial cancer has a relatively high survival 
rate; however, the one-year survival will be very different to 
mortality rates and may reflect the individual’s underlying 
comorbidities which may lead to earlier demise. Therefore, 
it is difficult to compare all different measures of mortality.
Despite increasing recognition of the impact of socio-
economic deprivation on survival of endometrial cancer 
patients, questions about the strength of its impact and rela-
tionship with other prognostic factors remain. To address 
these questions, more studies are needed which measure 
socioeconomic deprivation with a standardised measure and 
also correct for other prognostic variables including BMI, 
comorbidities and smoking status. From this knowledge, 
interventions to improve survival in lower SES patients can 
then be introduced.
Overall completeness and applicability of evidence
The majority of women were diagnosed with stage I disease, 
consistent with reported incidence rates [40]. Literature was 
scarce about the correlation between socioeconomic depri-
vation and peri-operative morbidity and we only found one 
study that evaluated peri-operative outcomes and SES in 
endometrial cancer patients.
Quality of evidence
The studies included were of a high degree of heterogeneity 
in study design and evaluated a variety of socioeconomic 
status measures, which lacked in uniformity. Different meas-
ures were used, each capturing a distinct aspect of SES, 
which may be correlated with other measures, but are not 
interchangeable [41]. Furthermore, individual SES meas-
ures such as income and occupation differ from environ-
mental SES measures, which are area-based, and these two 
measures often do not correlate well [42]. These different 
measures can all impact results. Area-based measures may 
not accurately represent a patient’s socioeconomic depriva-
tion status, since not all people living in low income are 
poor themselves. Furthermore, there is a large variety in 
definitions of socioeconomic deprivation: the definition of 
a deprived person living in the United States might be dif-
ferent from a deprived person living in Japan. In addition, 
in some studies, only one indicator of SES was used, while 
others used multiple measures. Furthermore, most studies 
have not adjusted for important confounders. Therefore, it 
is difficult to draw firm conclusions about the strength of 
the evidence.
Potential biases in review process
A comprehensive search of the literature with aid of librarian 
was performed by two reviewers independently, including a 
search of the grey literature. Reviewers assessed potentially 
eligible articles independently and discussed the differences 
found.
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Comparison with the existing literature
A previous review done by Kogevinas et al. [8] about 
socioeconomic differences in cancer survival included six 
studies about endometrial cancer and showed survival was 
poorest in low socioeconomic groups in five studies; in 
three of those studies, differences were statistically signifi-
cant. However, the reverse pattern was seen in one study. 
The association of inequality in survival is supported by 
several studies that have assessed the association between 
SES and cancer survival in general and that also included 
endometrial cancer patients [43–53], even though several 
other studies did not find any association between depriva-
tion and mortality [54–58].
Conclusion
Socioeconomic deprivation seems to be associated with 
poorer survival in endometrial cancer patients, regard-
less of their stage at diagnosis. However, important con-
founders such as BMI, comorbidities and smoking status 
should be taken into account. The relationship between 
peri-operative morbidity and socioeconomic deprivation 
is not clear.
Implications for clinical practice
• Socioeconomic deprivation status should be included 
in the initial evaluation of new patients diagnosed with 
endometrial cancer.
• Early and non-invasive diagnostic testing is needed in the 
community to improve access to health care in deprived 
groups.
• Early referral to cancer support teams is recommended.
Implications for research
• Further research should be directed to establish any rela-
tionship between socioeconomic deprivation and peri-
operative morbidity in endometrial cancer patients.
• Furthermore, a standardised measure for socioeconomic 
deprivation is needed in order to establish adequate com-
parison between studies.
• Further studies should adjust for important confounders 
such as BMI, comorbidities and smoking to assess the 
true extent of socioeconomic deprivation on survival in 
endometrial cancer patients.
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